| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,500 | $224.50 | $336,750.00 | -1.5% | +3.3% | -14.6% | |
| Feb 3, 2023 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 683 | $2.47 | $1,689.88 | -0.6% | - | - | |
| Feb 3, 2023 | BDX Becton Dickinson & Co | Byrd Richard64 | EVP &President Interventional | Sell | 1,421 | $248.60 | $353,260.60 | -25.6% | +3.1% | -2.1% | |
| Feb 3, 2023 | WRBY Warby Parker Inc. | Durable Capital Partners LP56 | 10% Owner | Sell | 575,894 | $17.27 | $9,944,168.17 | -0.2% | -31.4% | -16.4% | |
| Feb 2, 2023 | KIDS Orthopediatrics Corp | Odle Gregory A76 | Executive Vice President | Sell | 1,195 | $50.00 | $59,753.59 | -1.6% | -2.9% | -47.3% | |
| Feb 2, 2023 | SYK Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | Sell | 4,058 | $279.79 | $1,135,369.85 | -38.3% | +1.6% | +21.1% | |
| Feb 2, 2023 | RMD Resmed Inc | Drexler Karen49 | Director | Sell | 594 | $226.58 | $134,588.52 | -6.9% | +4.5% | -15.3% | |
| Feb 2, 2023 | ICUI Icu Medical Inc/de | Woolson Daniel56 | VP, Gm-infusion Capital | Sell | 1,731 | $200.00 | $346,200.00 | -15.9% | -5.3% | -54.1% | |
| Feb 2, 2023 | Pfeil Keith W69 | SVP, Chief Financial Officer | Sell | 29,167 | $77.57 | $2,262,425.86 | -100% | -27.7% | -34.1% | ||
| Feb 2, 2023 | SYK Stryker Corp | Boehnlein Glenn S | VP, Chief Financial Officer | Sell | 24,425 | $278.54 | $6,803,355.58 | -40.7% | +1.6% | +21.1% | |
| Feb 2, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 4,011 | $24.00 | $96,264.00 | -0.3% | +5.4% | -42.7% | |
| Feb 2, 2023 | SYK Stryker Corp | Pierce James Andrew | Group President | Sell | 400 | $277.88 | $111,152.00 | -0.8% | +1.6% | +21.1% | |
| Feb 2, 2023 | MXCT Maxcyte, Inc. | Doerfler Douglas81 | President And CEO | Sell | 30,000 | $5.72 | $171,553.20 | -4.3% | -16.6% | -12.6% | |
| Feb 2, 2023 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Technology Officer | Sell | 11,564 | $9.91 | $114,641.88 | -0.6% | -38.6% | -32.8% | |
| Feb 2, 2023 | OM Outset Medical, Inc. | Vazquez Martin84 | Chief Operating Officer | Sell | 24,500 | $29.57 | $724,553.50 | -5.5% | -32.9% | -90.3% | |
| Feb 2, 2023 | MXCT Maxcyte, Inc. | Ross Thomas M.82 | EVP, Global Sales &Marketing | Sell | 29,133 | $5.72 | $166,517.19 | -100% | -16.6% | -12.6% | |
| Feb 2, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 20,000 | $23.86 | $477,160.00 | -2.4% | -30.0% | -29.0% | |
| Feb 2, 2023 | MASS 908 Devices Inc. | Turner Michael S.75 | VP, General Counsel | Sell | 4,427 | $9.72 | $43,016.39 | -60.9% | -38.6% | -32.8% | |
| Feb 2, 2023 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 5,102 | $9.72 | $49,594.10 | -2.7% | -38.6% | -32.8% | |
| Feb 2, 2023 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 44,049 | $10.40 | $458,298.64 | -4.5% | -38.6% | -32.8% | |
| Feb 2, 2023 | AVTR Avantor, Inc. | Brophy Gerard75 | EVP, Biopharma Production | Sell | 11,339 | $25.06 | $284,155.34 | -10.0% | -18.8% | -5.9% | |
| Feb 1, 2023 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 5,000 | $62.64 | $313,200.00 | -46.7% | +13.0% | +35.5% | |
| Feb 1, 2023 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 1,410 | $63.14 | $89,028.58 | -1.9% | +13.0% | +35.5% | |
| Feb 1, 2023 | PEN Penumbra Inc | Bose Arani57 | Director | Sell | 5,000 | $254.21 | $1,271,074.62 | -0.2% | +9.3% | -1.1% | |
| Feb 1, 2023 | MASS 908 Devices Inc. | Fitzpatrick Maura | VP, Product Management &Mktg | Sell | 1,593 | $9.20 | $14,655.60 | -36.0% | -38.8% | -23.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.